SC
FLNA

Sculptor Capital’s Filana Therapeutics FLNA Stock Holding History

Sculptor Capital’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-236,100
Closed -$3.93M – 400
2023
Q3 		$3.93M Buy
+236,100
New +$4.68M 0.08% 110
2022
Q4 		– Sell
-76,500
Closed -$3.2M – 885
2022
Q3 		$3.2M Hold
76,500
– – 0.04% 440
2022
Q2 		$2.15M Buy
76,500
+70,300
+1,134% +$1.78M 0.02% 537
2022
Q1 		$230K Sell
6,200
-168,800
-96% -$7.15M ﹤0.01% 821
2021
Q4 		$7.65M Buy
+175,000
New +$9.18M 0.06% 256

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sculptor Capital's FLNA Position: Q2 2024 in Review

Sculptor Capital sold out of Filana Therapeutics (FLNA) in Q2 2024, closing a stake of 32,270 shares — an estimated $655K sold.

Sculptor Capital first reported a position in FLNA in Q3 2020 and held it in 10 quarters. The position peaked at $14.7M in Q3 2021. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.

  • Sculptor Capital reported no remaining Filana Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Sculptor Capital sold 32,270 Filana Therapeutics shares in Q2 2024, an estimated $655K.
  • Sculptor Capital first reported a position in Filana Therapeutics in Q3 2020 and held it in 10 quarters.
  • Sculptor Capital's Filana Therapeutics position peaked at $14.7M in Q3 2021.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.

Based on Sculptor Capital's 13F filing for Q2 2024, filed 14 Aug 2024.